Dalip Sethi – VJRegenMed https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Fri, 28 Jan 2022 09:23:19 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png Dalip Sethi – VJRegenMed https://mirror.vjregenmed.com 32 32 Automated cell culture in cell & gene therapy https://mirror.vjregenmed.com/video/zhergdsfbqq-automated-cell-culture-in-cell-gene-therapy/ Wed, 10 Mar 2021 19:30:20 +0000 http://13.40.107.223/video/zhergdsfbqq-automated-cell-culture-in-cell-gene-therapy/ Dalip Sethi, PhD, Terumo BCT, Lakewood, CO, describes the features of the Quantum Cell Expansion System, an automated cell culture device used for culturing a variety of cell types, and how this technology can be used in the cell and gene therapy space. This interview took place during the CAR-TCR Summit Europe 2021.

]]>
Automation in cell therapy manufacturing: enhancing the fill and finish step https://mirror.vjregenmed.com/video/d9dyawzf01q-automation-in-cell-therapy-manufacturing-enhancing-the-fill-and-finish-step/ Wed, 10 Mar 2021 19:30:19 +0000 http://13.40.107.223/video/d9dyawzf01q-automation-in-cell-therapy-manufacturing-benefits-to-the-fill-and-finish-step/ Dalip Sethi, PhD, Terumo BCT, Lakewood, CO, highlights the importance of the fill and finish step in cell therapy manufacturing and describes how the use of automation technologies can enhance this manufacturing process such as through reducing error, variability and contamination. This interview took place during the CAR-TCR Summit Europe 2021.

]]>
CAR-TCR Europe highlights: synthetic biology & the autologous vs allogeneic debate https://mirror.vjregenmed.com/video/8wp7m4fgul8-car-tcr-europe-highlights-synthetic-biology-the-autologous-vs-allogeneic-debate/ Wed, 10 Mar 2021 19:30:13 +0000 http://13.40.107.223/video/8wp7m4fgul8-car-tcr-europe-highlights-synthetic-biology-the-autologous-vs-allogeneic-debate/ Dalip Sethi, PhD, Terumo BCT, Lakewood, CO, describes his highlights from the CAR-TCR Summit Europe 2021 including how exciting advances seen in the field of synthetic biology could lead to significant developments in the field in the coming years. He also discusses the ongoing debate between autologous and allogeneic approaches and how he expects the use of these technologies will evolve and lead to benefits in patients suffering from a wide range of cancer types. This interview took place during the CAR-TCR Summit Europe 2021.

]]>